Browse: Companies | People | Financial Organizations
Home > Companies > Singulex

General Information

Websitesingulex.com
CategoryOther
Phone510.995.9040
Email
Employees25
Founded2003
Descriptionbiotechnology

Offices

HQ
1650 Harbor Bay Parkway, Suite 200
Alameda, CA, 94502-3012
USA

Funding

Tags

Singulex

Singulex, Inc., a biotechnology company, develops and commercializes direct molecular detection technology solutions. Its solutions enable life science researchers and clinicians to understand and manage disease. The company develops biomarker diagnostic systems that can detect and quantify normal and abnormal protein biomarkers. It is conducting pilot studies to validate Erenna BioAssay System, a digital molecule detection platform, which detects and quantifies molecule biomarkers in clinical samples. The company also offers various custom assay services, such as pilot study services, assay prototyping, assay characterization, and assay validation. The company was formerly known as BioProfile Corporation and changed its name to Singulex, Inc in September 2003. Singulex is based in Hayward, California

Milestones

  • Received $19M in Series E funding. (1/12/09)
    Posted 6/13/09 at 8:21am
  • Received $19M in Series D funding. (6/7/07)
    Posted 6/19/09 at 11:14am

Videos

Screenshots

Singulex screenshot
Above: Singulex Screenshot -- #1
Uploaded: 6/13/09

Sources

  1. Biomarker-diagnostics developer Singulex validates $19M (venturebeat.com) [edit]
  2. Singulex Closes $19 Million Financing Round (bio-medicine.org) [edit]
Edit This Page
Last Edited 6/19/09

Revision History RSS Picture

External Links

Embed Widget

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy